Ferroptosis Heterogeneity in Triple-Negative Breast Cancer Reveals an Innovative Immunotherapy Combination Strategy

Investigators discovered that TNBCs had heterogeneous phenotypes in ferroptosis-related metabolites and metabolic pathways.